Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in fibrogen, inc. of class action lawsuit and upcoming deadline - fgen

New york, june 1, 2021 /prnewswire/ -- pomerantz llp announces that a class action lawsuit has been filed against fibrogen, inc. ("fibrogen" or the "company") (nasdaq: fgen) and certain of its officers. the class action, filed in the united states district court for the northern district of california, and docketed under 21-cv-03212, is on behalf of a class consisting of all persons and entities other than defendants who purchased or otherwise acquired fibrogen securities and/or sold put options from november 8, 2019, through and including april 6, 2021 (the "class period"), seeking to recover damages pursuant to sections 10(b) and 20(a) of the securities exchange act of 1934 (the "exchange act"), 15 u.s.c.
FGEN Ratings Summary
FGEN Quant Ranking